Gap Junction Protein, alpha 8, 50kDa (GJA8) (Middle Region) Peptide
GJA8
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all GJA8 products
- GJA8 (Gap Junction Protein, alpha 8, 50kDa (GJA8))
- Protein Region
- Middle Region
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-GJA8 antibody (Catalog #: ARP36612_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- GJA8 (Gap Junction Protein, alpha 8, 50kDa (GJA8))
- Background
-
One gap junction consists of a cluster of closely packed pairs of transmembrane channels, the connexons, through which materials of low MW diffuse from one cell to a neighboring cell. Defects in GJA8 are the cause of zonular pulverulent cataract type 1 (CZP1).
Alias Symbols: CAE, CAE1, CX50, CZP1, MP70
Protein Interaction Partner: MIP,TJP1,TJP1
Protein Size: 433 - Molecular Weight
- 48 kDa
- Gene ID
- 2703
- NCBI Accession
- NM_005267, NP_005258
- UniProt
- P48165
-
You are here:
